DE69932846D1 - Neue 4-dedimethylaminotetracyclinderivate - Google Patents
Neue 4-dedimethylaminotetracyclinderivateInfo
- Publication number
- DE69932846D1 DE69932846D1 DE69932846T DE69932846T DE69932846D1 DE 69932846 D1 DE69932846 D1 DE 69932846D1 DE 69932846 T DE69932846 T DE 69932846T DE 69932846 T DE69932846 T DE 69932846T DE 69932846 D1 DE69932846 D1 DE 69932846D1
- Authority
- DE
- Germany
- Prior art keywords
- dedimethylaminotetracyclin
- derivatives
- new
- compounds
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/82—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
- C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/20—Diazonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/16—Compounds containing azido groups with azido groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C247/18—Compounds containing azido groups with azido groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
- C07C329/12—Dithiocarbonic acids; Derivatives thereof
- C07C329/14—Esters of dithiocarbonic acids
- C07C329/20—Esters of dithiocarbonic acids having sulfur atoms of dithiocarbonic groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
- C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
- C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10894898P | 1998-11-18 | 1998-11-18 | |
US19501398A | 1998-11-18 | 1998-11-18 | |
US108948P | 1998-11-18 | ||
US195013 | 1998-11-18 | ||
PCT/US1999/027304 WO2000028983A1 (en) | 1998-11-18 | 1999-11-18 | Novel 4-dedimethy laminotetra cycline derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69932846D1 true DE69932846D1 (de) | 2006-09-28 |
DE69932846T2 DE69932846T2 (de) | 2007-03-15 |
Family
ID=26806459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69932846T Expired - Lifetime DE69932846T2 (de) | 1998-11-18 | 1999-11-18 | Neue 4-dedimethylaminotetracyclinderivate |
Country Status (13)
Country | Link |
---|---|
EP (2) | EP1137410B1 (de) |
JP (3) | JP5060685B2 (de) |
KR (1) | KR100701635B1 (de) |
AT (1) | ATE336238T1 (de) |
AU (1) | AU766200B2 (de) |
CA (1) | CA2351703C (de) |
CY (1) | CY1106224T1 (de) |
DE (1) | DE69932846T2 (de) |
DK (1) | DK1137410T3 (de) |
ES (1) | ES2272097T3 (de) |
NZ (1) | NZ511194A (de) |
PT (1) | PT1137410E (de) |
WO (1) | WO2000028983A1 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1137410B1 (de) * | 1998-11-18 | 2006-08-16 | Collagenex Pharmaceuticals, Inc. | Neue 4-dedimethylaminotetracyclinderivate |
US6506740B1 (en) | 1998-11-18 | 2003-01-14 | Robert A. Ashley | 4-dedimethylaminotetracycline derivatives |
US6946453B2 (en) | 1998-11-18 | 2005-09-20 | Collagenex Pharmaceuticals, Inc. | 4-dedimethylaminotracycline derivatives |
EP1679305B1 (de) | 2000-07-07 | 2012-02-08 | Trustees Of Tufts College | 9-substituierte Minocyclinverbindungen |
AU2001271556A1 (en) * | 2000-07-07 | 2002-01-21 | Trustees Of Tufts College | 7,8 and 9-substituted tetracycline compounds |
KR101027625B1 (ko) * | 2000-07-07 | 2011-04-06 | 파라테크 파마슈티컬스, 인크. | 7-치환 테트라사이클린 화합물 |
US7553828B2 (en) | 2001-03-13 | 2009-06-30 | Paratek Pharmaceuticals, Inc. | 9-aminomethyl substituted minocycline compounds |
WO2002072506A2 (en) | 2001-03-13 | 2002-09-19 | Paratek Pharmaceuticals, Inc. | 7-pyrollyl tetracycline compounds and methods of use thereof |
ATE404528T1 (de) | 2001-03-13 | 2008-08-15 | Paratek Pharm Innc | 7,9 substituierte tetracyclinverbindungen |
US7211267B2 (en) | 2001-04-05 | 2007-05-01 | Collagenex Pharmaceuticals, Inc. | Methods of treating acne |
AU2002303250B2 (en) * | 2001-04-05 | 2006-05-25 | Collagenex Pharmaceuticals, Inc. | Methods of treating acne |
EP1383483A4 (de) * | 2001-04-05 | 2006-08-09 | Collagenex Pharm Inc | Kontrollierte freisetzung von tetracyclin-verbindungen und tetracyclin-derivativen |
US8088820B2 (en) | 2001-04-24 | 2012-01-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for the treatment of malaria |
US20040092490A1 (en) * | 2001-04-24 | 2004-05-13 | Michael Draper | Substituted tetracycline compounds for the treatment of malaria |
EP2301550A1 (de) * | 2001-07-13 | 2011-03-30 | Paratek Pharmaceuticals, Inc. | Tetracyclinverbindungen mit therapeutischen Targetwirkungen |
WO2003055441A2 (en) | 2001-08-02 | 2003-07-10 | Paratek Pharmaceuticals, Inc. | Medicaments |
CA2462572C (en) * | 2001-10-05 | 2008-11-18 | Tetragenex Pharmaceuticals, Inc. | Tetracycline derivatives and methods of use thereof |
EP2311799A1 (de) * | 2002-01-08 | 2011-04-20 | Paratek Pharmaceuticals, Inc. | 4-Dedimethylamin-Tetracyclinverbindungen |
KR20040094833A (ko) * | 2002-03-29 | 2004-11-10 | 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 | 비-항균성 테트라사이클린 동족체의 용도 및 박테리아외독소의 치료를 위한 이의 제형 |
US8173624B2 (en) | 2002-10-24 | 2012-05-08 | Paratek Pharmaceuticals, Inc. | Methods of using substituted tetracycline compounds to modulate RNA |
EP2277504A1 (de) * | 2002-10-24 | 2011-01-26 | Paratek Pharmaceuticals, Inc. | Substituierte Tetracyclin-Verbindungen zur Behandlung von Malaria |
EA201100956A1 (ru) | 2003-07-09 | 2012-01-30 | Пэрэтек Фамэсьютикэлс, Инк. | Замещенные соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта |
EP2026776A2 (de) | 2006-05-15 | 2009-02-25 | Paratek Pharmaceuticals, Inc. | Verfahren zur regelung der genexpression oder genprodukte mithilfe von substituierten tetracyclinverbindungen |
PT2225253E (pt) | 2007-11-29 | 2012-09-19 | Actelion Pharmaceuticals Ltd | Derivados de ácido fosfónico e respetiva utilização como antagonistas do recetor p2y12 |
PT2271348T (pt) | 2008-03-28 | 2018-04-16 | Paratek Pharm Innc | Formulação de comprimido oral de composto de tetraciclina |
TW202216656A (zh) | 2008-05-23 | 2022-05-01 | 美商Prtk Spv2公司 | 四環素化合物之甲苯磺酸鹽及同素異形體 |
CN110156624B (zh) * | 2019-05-29 | 2022-03-08 | 河北冀衡药业股份有限公司 | 一种米诺环素及其衍生物的合成方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2786077A (en) * | 1954-10-22 | 1957-03-19 | Pfizer & Co C | Desdimethylaminotetracyclines and process |
DE1088481B (de) * | 1958-01-29 | 1960-09-08 | American Cyanamid Co | Verfahren zur Herstellung neuer Verbindungen der Tetracyclinreihe |
US3375276A (en) * | 1963-06-24 | 1968-03-26 | Squibb & Sons Inc | Method for preparing tetracycline products |
US3159675A (en) * | 1963-12-10 | 1964-12-01 | American Cyanamid Co | Novel 4-dedimethylamino-4-oxo-6-demethyltetracycline-4-oximes and 4-hydrazones |
US3247226A (en) * | 1964-07-06 | 1966-04-19 | American Cyanamid Co | 4-dimethylamino and 4-hydroxytetracycloxides |
US3345370A (en) * | 1965-03-16 | 1967-10-03 | American Cyanamid Co | 4-(n-mono-substituted) hydrazones of 4-dedimethylamino-4-oxo-tetracycline |
US3849493A (en) * | 1966-08-01 | 1974-11-19 | Pfizer | D-ring substituted 6-deoxytetracyclines |
US3824285A (en) * | 1967-09-13 | 1974-07-16 | Pfizer | 4-oxo-4-dedimethylaminotetracycline-4,6-hemiketals |
US5122519A (en) * | 1989-06-27 | 1992-06-16 | American Cyanamid Company | Stable, cosmetically acceptable topical gel formulation and method of treatment for acne |
US5045538A (en) * | 1990-06-28 | 1991-09-03 | The Research Foundation Of State University Of New York | Inhibition of wasting and protein degradation of mammalian muscle by tetracyclines |
US5442059A (en) * | 1992-08-13 | 1995-08-15 | American Cyanamid Company | 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines |
KR20010073190A (ko) * | 1998-09-28 | 2001-07-31 | 제임스 알. 데니히 | 백내장 형성 억제제 |
EP1137410B1 (de) * | 1998-11-18 | 2006-08-16 | Collagenex Pharmaceuticals, Inc. | Neue 4-dedimethylaminotetracyclinderivate |
-
1999
- 1999-11-18 EP EP99967109A patent/EP1137410B1/de not_active Expired - Lifetime
- 1999-11-18 NZ NZ511194A patent/NZ511194A/en not_active IP Right Cessation
- 1999-11-18 DK DK99967109T patent/DK1137410T3/da active
- 1999-11-18 DE DE69932846T patent/DE69932846T2/de not_active Expired - Lifetime
- 1999-11-18 PT PT99967109T patent/PT1137410E/pt unknown
- 1999-11-18 ES ES99967109T patent/ES2272097T3/es not_active Expired - Lifetime
- 1999-11-18 AT AT99967109T patent/ATE336238T1/de active
- 1999-11-18 CA CA002351703A patent/CA2351703C/en not_active Expired - Fee Related
- 1999-11-18 AU AU23456/00A patent/AU766200B2/en not_active Ceased
- 1999-11-18 EP EP06076306A patent/EP1743632A1/de not_active Withdrawn
- 1999-11-18 KR KR1020017006216A patent/KR100701635B1/ko not_active IP Right Cessation
- 1999-11-18 WO PCT/US1999/027304 patent/WO2000028983A1/en active IP Right Grant
- 1999-11-18 JP JP2000582031A patent/JP5060685B2/ja not_active Expired - Fee Related
-
2006
- 2006-10-30 CY CY20061101555T patent/CY1106224T1/el unknown
-
2009
- 2009-09-30 JP JP2009228453A patent/JP2010043102A/ja active Pending
-
2010
- 2010-10-25 JP JP2010238591A patent/JP5130417B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1137410A4 (de) | 2002-06-26 |
KR20010082303A (ko) | 2001-08-29 |
PT1137410E (pt) | 2007-01-31 |
KR100701635B1 (ko) | 2007-03-30 |
JP2002529501A (ja) | 2002-09-10 |
JP5130417B2 (ja) | 2013-01-30 |
CA2351703A1 (en) | 2000-05-25 |
DK1137410T3 (da) | 2006-12-27 |
CA2351703C (en) | 2008-12-30 |
EP1137410B1 (de) | 2006-08-16 |
ATE336238T1 (de) | 2006-09-15 |
JP2010043102A (ja) | 2010-02-25 |
AU2345600A (en) | 2000-06-05 |
ES2272097T3 (es) | 2007-04-16 |
EP1743632A1 (de) | 2007-01-17 |
WO2000028983A1 (en) | 2000-05-25 |
JP2011021032A (ja) | 2011-02-03 |
AU766200B2 (en) | 2003-10-09 |
DE69932846T2 (de) | 2007-03-15 |
EP1137410A1 (de) | 2001-10-04 |
NZ511194A (en) | 2003-08-29 |
CY1106224T1 (el) | 2011-06-08 |
JP5060685B2 (ja) | 2012-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69932846D1 (de) | Neue 4-dedimethylaminotetracyclinderivate | |
IL175398A0 (en) | Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation | |
EE200100645A (et) | Amüloidogeense haiguse preventsioon ja ravi | |
ATE334668T1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
HK1037320A1 (en) | Use of anti.microtubule agents for treating inflammatory respiratory diseases of the respiratory tract | |
ATE492525T1 (de) | Phenyl-benzyl-ketone | |
DE69716810T2 (de) | 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one | |
BR9804027A (pt) | Novos beta-ceto ésteres | |
NO20003229L (no) | Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske midler for behandling av proliferaktive sykdommer | |
DE69825605D1 (de) | Behandlung der schizophrenie und der psychose | |
DE69832695D1 (de) | Verwendung von r-enantiomeren nichtsteroidaler entzündungshemmer zur vorbeugung der alzheimerschen krankheit | |
FI962685A (fi) | 2,3-diaryyli-1-bentsopyraanijohdannaisten käyttö lääkkeen valmistamiseksi luukadon ja osteoporoosin hoitamiseksi ja estämiseksi | |
ES2177024T3 (es) | Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer. | |
DE69300321D1 (de) | Behandlung neurodegenerativer Erkrankungen. | |
DE69418744T2 (de) | Verwendung von Pregnanderivaten zur Behandlung von Tumoren | |
ES2085898T3 (es) | Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina. | |
ES2150418T3 (es) | Composiciones farmaceuticas que comprenden calcitonina. | |
ATE470671T1 (de) | Verbindungen mit wachstumshormon-freisetzender eigenschaft | |
BR9915292A (pt) | Associação, utilização de riluzol e composição farmacêutica. | |
PT821955E (pt) | Uso de 3-(4-hexiloxi-1,2,5-tiadiazol-3-il)-1,2,5,6-tetrahidro-1-metilpiridina (xanomelina) para o tratamento da doenca bipolar | |
BR9507732A (pt) | Composição farmacêutica para o tratamento de glaucoma | |
ITMI920106A1 (it) | Composizioni farmaceutiche comprendenti melatonina o un suo derivato-agonista, atte al trattamento dei disordini cerebro-vascolari | |
GR3036968T3 (en) | Adamantyl substituted oxindoles as pharmaceutical agents | |
BR1100506A (pt) | Composição para o tratamento de um ser humano sofrendo de um distúrbio intestinal. | |
DE564648T1 (de) | Neue aconitinverbindung und analgetisches/entzündungshemmendes mittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |